Rongyu Y. Liu
Heping Road 246
Hefei, 230022, China
Hefei, 230022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Influencing factors of poor treatment adherence in uncontrolled asthma patients in China
Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: February 05, 2023
Associations between comorbidities and annual incidence plus frequency of asthma exacerbation hospitalisation during the past year: data from CARN study.
Journal: BMC pulmonary medicine
Published: January 30, 2022
Occupational fibrotic hypersensitivity pneumonia in a halogen dishes manufacturer: A case report.
Journal: World journal of clinical cases
Published: August 19, 2021
Asthma Management Using the Mobile Asthma Evaluation and Management System in China.
Journal: Allergy, asthma & immunology research
Published: April 14, 2021
Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first-line treatment for Chinese patients with unresectable, metastatic, or recurrent non-squamous non-small-cell lung cancer: A multicenter, randomized, double-blinded, phase III trial.
Journal: Cancer communications (London, England)
Published: January 16, 2021
Hospitalization Due to Asthma Exacerbation: A China Asthma Research Network (CARN) Retrospective Study in 29 Provinces Across Mainland China.
Journal: Allergy, asthma & immunology research
Published: October 12, 2019
Alda-1 Prevents Pulmonary Epithelial Barrier Dysfunction following Severe Hemorrhagic Shock through Clearance of Reactive Aldehydes.
Journal: BioMed research international
Published: March 21, 2019
PI3K/Akt-Beclin1 signaling pathway positively regulates phagocytosis and negatively mediates NF-κB-dependent inflammation in Staphylococcus aureus-infected macrophages.
Journal: Biochemical and biophysical research communications
Published: January 15, 2019
Peroxisome Proliferator Activated Receptor gamma (PPARγ) Agonist Rosiglitazone Ameliorate Airway Inflammation by Inhibiting Toll-Like Receptor 2 (TLR2)/Nod-Like Receptor with Pyrin Domain Containing 3 (NLRP3) Inflammatory Corpuscle Activation in Asthmatic Mice.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: December 14, 2018
Seasonal distribution of patient hospitalization due to asthma exacerbation in 7 geographic areas in China
Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Published: November 22, 2018
Last Updated: 09/26/2026